Life
Gilead's Refusal to Supply Lenacapavir Raises Concerns for HIV Prevention Efforts
Doctors Without Borders has criticized Gilead Sciences for declining to provide lenacapavir, a crucial HIV prevention drug, after lengthy negotiations.
Editorial Staff
1 min read
Doctors Without Borders has sought a limited supply of lenacapavir, an innovative drug for HIV prevention, from Gilead Sciences.
After months of negotiations, Gilead's refusal to meet the request has raised alarms among health advocates regarding access to essential medications.
This decision may have significant implications for public health strategies aimed at combating HIV, particularly in vulnerable populations.